Literature DB >> 18981165

Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.

Emma Guttman-Yassky1, Michelle A Lowes, Judilyn Fuentes-Duculan, Lisa C Zaba, Irma Cardinale, Kristine E Nograles, Artemis Khatcherian, Inna Novitskaya, John A Carucci, Reuven Bergman, James G Krueger.   

Abstract

The classical Th1/Th2 paradigm previously defining atopic dermatitis (AD) and psoriasis has recently been challenged with the discovery of Th17 T cells that synthesize IL-17 and IL-22. Although it is becoming evident that many Th1 diseases including psoriasis have a strong IL-17 signal, the importance of Th17 T cells in AD is still unclear. We examined and compared skin biopsies from AD and psoriasis patients by gene microarray, RT-PCR, immunohistochemistry, and immunofluorescence. We found a reduced genomic expression of IL-23, IL-17, and IFN-gamma in AD compared with psoriasis. To define the effects of IL-17 and IL-22 on keratinocytes, we performed gene array studies with cytokine-treated keratinocytes. We found lipocalin 2 and numerous other innate defense genes to be selectively induced in keratinocytes by IL-17. IFN-gamma had no effect on antimicrobial gene-expression in keratinocytes. In AD skin lesions, protein and mRNA expression of lipocalin 2 and other innate defense genes (hBD2, elafin, LL37) were reduced compared with psoriasis. Although AD has been framed by the Th1/Th2 paradigm as a Th2 polar disease, we present evidence that the IL-23/Th17 axis is largely absent, perhaps accounting for recurrent skin infections in this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981165      PMCID: PMC3470474          DOI: 10.4049/jimmunol.181.10.7420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  The immunologic basis for the treatment of psoriasis with new biologic agents.

Authors:  James G Krueger
Journal:  J Am Acad Dermatol       Date:  2002-01       Impact factor: 11.527

2.  Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions.

Authors:  Masao Toda; Donald Y M Leung; Sophie Molet; Mark Boguniewicz; Rame Taha; Pota Christodoulopoulos; Takeshi Fukuda; Jack A Elias; Qutayba A Hamid
Journal:  J Allergy Clin Immunol       Date:  2003-04       Impact factor: 10.793

3.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 4.  Atopic dermatitis.

Authors:  Donald Y M Leung; Thomas Bieber
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

5.  Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

Authors:  Michelle A Lowes; Toyoko Kikuchi; Judilyn Fuentes-Duculan; Irma Cardinale; Lisa C Zaba; Asifa S Haider; Edward P Bowman; James G Krueger
Journal:  J Invest Dermatol       Date:  2008-01-17       Impact factor: 8.551

6.  The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.

Authors:  David M Hoover; Cyril Boulegue; De Yang; Joost J Oppenheim; Kenneth Tucker; Wuyuan Lu; Jacek Lubkowski
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

7.  Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.

Authors:  Ichiro Nomura; Elena Goleva; Michael D Howell; Quatyba A Hamid; Peck Y Ong; Clifton F Hall; Marc A Darst; Bifeng Gao; Mark Boguniewicz; Jeffrey B Travers; Donald Y M Leung
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

8.  CCL20 is an inducible product of human airway epithelia with innate immune properties.

Authors:  Timothy D Starner; Carrie K Barker; Hong Peng Jia; Yubin Kang; Paul B McCray
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05-14       Impact factor: 6.914

9.  Epicutaneous sensitization with superantigen induces allergic skin inflammation.

Authors:  Dhafer Laouini; Seiji Kawamoto; Ali Yalcindag; Paul Bryce; Emiko Mizoguchi; Hans Oettgen; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

10.  Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.

Authors:  Edmund Lee; William L Trepicchio; Judith L Oestreicher; Debra Pittman; Frank Wang; Francesca Chamian; Madhav Dhodapkar; James G Krueger
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

View more
  107 in total

1.  Staphylococcus aureus: an introduction.

Authors:  Ian A Myles; Sandip K Datta
Journal:  Semin Immunopathol       Date:  2012-01-27       Impact factor: 9.623

2.  Pathways to managing atopic dermatitis: consensus from the experts.

Authors:  Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

3.  Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis.

Authors:  Lisa C Zaba; Judilyn Fuentes-Duculan; Narat John Eungdamrong; Leanne M Johnson-Huang; Kristine E Nograles; Traci R White; Katherine C Pierson; Tim Lentini; Mayte Suárez-Fariñas; Michelle A Lowes; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2010-05-14       Impact factor: 10.793

4.  Adaptive Immunity Against Staphylococcus aureus.

Authors:  Hatice Karauzum; Sandip K Datta
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

5.  Relationship Between Serum Interleukin-17F Level and Severity of Atopic Dermatitis in Children.

Authors:  Young A Park; Yoon Hee Kim; In Suk Sol; Seo Hee Yoon; Jung Yeon Hong; Mi Na Kim; Kyung Eun Lee; Kyung Won Kim; Kyu-Earn Kim; Myung Hyun Sohn
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-06-01       Impact factor: 1.349

6.  T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets.

Authors:  Michael N Alonso; Michael T Wong; Angela L Zhang; Daniel Winer; Megan M Suhoski; Lorna L Tolentino; Juliana Gaitan; Matthew G Davidson; Tiffany H Kung; David M Galel; Kari C Nadeau; Jinah Kim; Paul J Utz; Kalle Söderström; Edgar G Engleman
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

7.  Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1.

Authors:  Michael S Garshick; Michael Tawil; Tessa J Barrett; Charissa M Salud-Gnilo; Michael Eppler; Angela Lee; Jose U Scher; Andrea L Neimann; Sanja Jelic; Nehal N Mehta; Edward A Fisher; James G Krueger; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-05       Impact factor: 8.311

8.  CD19 expression in B cells regulates atopic dermatitis in a mouse model.

Authors:  Koichi Yanaba; Masahiro Kamata; Yoshihide Asano; Yayoi Tada; Makoto Sugaya; Takafumi Kadono; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2013-04-12       Impact factor: 4.307

9.  Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin.

Authors:  Alexis Dumortier; André-Dante Durham; Matteo Di Piazza; Sophie Vauclair; Ute Koch; Gisèle Ferrand; Isabel Ferrero; Shadmehr Demehri; Lynda Li Song; Andrew G Farr; Warren J Leonard; Raphael Kopan; Lucio Miele; Daniel Hohl; Daniela Finke; Freddy Radtke
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

10.  Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.

Authors:  Malte Bachmann; Katharina Horn; Ina Rudloff; Itamar Goren; Martin Holdener; Urs Christen; Nicole Darsow; Klaus-Peter Hunfeld; Ulrike Koehl; Peter Kind; Josef Pfeilschifter; Peter Kraiczy; Heiko Mühl
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.